Azelastine Recruiting Phase 4 Trials for Allergic Rhinitis (AR) Basic Science

IndicationsStatusPurposePhase
RecruitingBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT02402465Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis